Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
大麻股票对缉毒局改期的反应：Canopy & Aurora Surge、Tilray、WM Tech保持稳定
In a historic trading session on Tuesday, cannabis stocks soared following the DEA's decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.
在周二的历史性交易时段中，在缉毒局决定根据《管制物质法》将大麻从附表一重新归类为附表三之后，大麻股票飙升。
This regulatory shift aligning with a recommendation from the Department of Health and Human Services, sparked investor interest
这种监管转变符合卫生与公共服务部的建议，激发了投资者的兴趣
evidenced by gains in major cannabis stocks on the NASDAQ.
纳斯达克主要大麻股票的涨势就证明了这一点。
Canopy Growth Corporation (NASDAQ:CGC) led the gains, skyrocketing by 78.8% to close at $14.88 per share amid a trading frenzy that pushed the volume to 79.25 million shares.
Canopy Growth Corporation（纳斯达克股票代码：CGC）领涨，飙升78.8％，收于每股14.88美元，交易狂潮将成交量推高至7,925万股。
Aurora Cannabis (NASDAQ:ACB) wasn't far behind, climbing 46.0% to close at $9.23 per share with a volume...
Aurora Cannabis（纳...
登录免费看全文
登录/注册